Amanda Axtman

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease

Steven I. Park, Jaideep Shenoi, John M. Pagel et al. · Blood · 2010 · 73 citations · Full text

Medicine, Immunology, Oncology +15

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

John M. Pagel, Aimee L. Kenoyer, Tom Bäck et al. · Blood · 2011 · 57 citations · Full text

Medicine, Hematology, Oncology +10

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

Steven Park, Jaideep Shenoi, Shani M. Frayo et al. · Clinical Cancer Research · 2011 · 30 citations · Full text

Pharmacy, Biotechnology, Oncology +17